Next Article in Journal
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge
Previous Article in Journal
Comparison of Post-Vaccination Response (Humoral and Cellular) to BNT162b2 in Clinical Cases, Kidney and Pancreas Transplant Recipient with Immunocompetent Subjects over Almost Two Years of Parallel Monitoring
Previous Article in Special Issue
Deletion of MGF505-2R Gene Activates the cGAS-STING Pathway Leading to Attenuation and Protection against Virulent African Swine Fever Virus
 
 
Article

Article Versions Notes

Vaccines 2024, 12(8), 845; https://doi.org/10.3390/vaccines12080845 (registering DOI)
Action Date Notes Link
article xml file uploaded 26 July 2024 11:45 CEST Original file -
article xml uploaded. 26 July 2024 11:45 CEST Update https://www.mdpi.com/2076-393X/12/8/845/xml
article pdf uploaded. 26 July 2024 11:45 CEST Version of Record https://www.mdpi.com/2076-393X/12/8/845/pdf
article supplementary file uploaded. 26 July 2024 11:45 CEST - https://www.mdpi.com/2076-393X/12/8/845#supplementary
article html file updated 26 July 2024 11:47 CEST Original file https://www.mdpi.com/2076-393X/12/8/845/html
Back to TopTop